Tevogen Bio: Funding, Investors & Team (Oct 2026)
A clinical stage biotech company developing curative and preventative treatments to positively impact global public health. Tevogen is developing T cell immunotherapies in virology, oncology, and neurology, by utilizing patented precision T cell platform technology. Its current intellectual property portfolio includes several breakthrough cell and gene therapy platforms.
Tevogen Bio has raised $39.0M across 2 funding rounds on record, the most recent an undisclosed round of $3.0M announced in May 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Tevogen Bio Company Profile and Key Stats
Latest funding round on record: May 2026.
Tevogen Bio Funding Rounds
Tevogen Bio raised $36.0M in an undisclosed round announced in May 2024.
2 years later, an undisclosed round of $3.0M was announced in May 2026.
Tevogen Bio Founders and Leadership Team
Contact details for the Tevogen Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Tevogen Bio Funding Compared to Other Biotechnology Startups
Tevogen Bio's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tevogen Bio in Biotechnology and Warren
Companies Similar to Tevogen Bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Tevogen Bio Funding FAQs
What does Tevogen Bio do?
A clinical stage biotech company developing curative and preventative treatments to positively impact global public health. Tevogen is developing T cell immunotherapies in virology, oncology, and neurology, by utilizing patented precision T cell platform technology. Its current intellectual property portfolio includes several breakthrough cell and gene therapy platforms.
How much funding has Tevogen Bio raised?
Tevogen Bio has raised $39.0M across 2 rounds on record. The most recent is an undisclosed round of $3.0M announced in May 2026.
When did Tevogen Bio last raise funding?
Tevogen Bio's most recent funding round on record is an undisclosed round of $3.0M, announced in May 2026.
Who founded Tevogen Bio?
FundedIQ lists Ryan Saadi (Founder) at Tevogen Bio.
Where is Tevogen Bio headquartered?
Tevogen Bio is based in Warren, New Jersey, United States.
How many employees does Tevogen Bio have?
Tevogen Bio is in the 11-50 employee band.
How does Tevogen Bio's funding compare to other Biotechnology startups?
Tevogen Bio's latest round of $3.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Tevogen Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tevogen Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.